Skip to main content
Clinical Trials/JPRN-UMIN000004703
JPRN-UMIN000004703
Completed
未知

Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastases - CSF concentrations treated with high dose weekly erlotinib in patients with CNS metastases

Osaka City University0 sites10 target enrollmentDecember 10, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
central nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinib
Sponsor
Osaka City University
Enrollment
10
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 10, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.IIPs 2\.drug hypersensitivity reaction with gefitinib or erlotinib 3\.high risk of brain herniation by lumbar puncture 4\.unsuitable for treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol following intravenous and oral administratio
ACTRN12615000322538Royal Melbourne Hospital21
Active, not recruiting
Not Applicable
Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte®) after intrathecal administration in children with malignant brain tumors and leptomeningeal disseminatioTo measure concentrations of liposomal cytarabine in CSF and plasma over time after intrathecal administration of liposomal cytarabine in children of different age groups with a malignant brain tumor and leptomenigeal dissemination. Measurements of concentrations of cytarabine after intrathecal administration of liposomal cytarabine will help to ensure proper dosage of liposomal cytarabine in small children, avoiding neurotoxic events and subtherapeutic drug levels.
EUCTR2006-004982-32-ATMedical University of Vienna, Department of Pedatrics
Not yet recruiting
Not Applicable
Cerebrospinal fluid concentrations of polyols following traumatic brain injuryneurotraumaTraumatic brain injury100184241002211410029305
NL-OMON56843Amsterdam UMC30
Completed
Not Applicable
The study analyzing blood and cerebrospinal fluids from the patients with early onset Alzheimer disease to discover causative factors and biomarkersDiseases of the nervous system
KCT0000847Soon Chun Hyang University Hospital Bucheon516
Completed
Not Applicable
An investigation on spinal fluid in patients with sciatica-type or nerve-type pain of the lower limbeuropathic lower limb painNervous System Diseases
ISRCTN34007592Trinity Translational Medicine Institute12